Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term

被引：0
|
作者：
Liqi Chen
Guoli Li
Jieshou Li
Chaogang Fan
Jian Xu
Bo Wu
Kun Liu
Caihua Zhang
机构：
[1] Medical School of Nanjing University,Department of Surgery, Jinling Hospital
[2] Medical School of Nanjing University,Department of Medical Imaging, Jinling Hospital
[3] Medical School of Nanjing University,Department of Pathology, Jinling Hospital
[4] Gastrointestinal Surgery of Xuzhou Central Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Gastric cancer; Preoperative chemotherapy; ERCC1; TS; Endarterial-intravenous coadministration; Real-time Fluorescent quantitative PCR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：921 / 928
页数：7
相关论文
共 50 条
  • [21] Prognostic Impact of ERCC1 Gene Polymorphisms in Gastric Cancer
    Metzger, Ralf
    Warnecke-Eberz, Ute
    Bollschweiler, Elfriede
    Brabender, Jan
    Vallbohmer, Daniel
    Hoelscher, Amulf H.
    GASTROENTEROLOGY, 2009, 136 (05) : A920 - A920
  • [22] Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy
    Lu, Zheng-mao
    Luo, Tian-hang
    Nie, Ming-ming
    Fang, Guo-en
    Ma, Li-ye
    Xue, Xu-chao
    Wei, Guo
    Ke, Chong-we
    Bi, Jian-wei
    TUMOR BIOLOGY, 2014, 35 (04) : 2941 - 2948
  • [23] Correlation of ERCC1 expression in peripheral blood lymphocytes with outcomes of patients with gastric cancer treated with oxaliplatin-based adjuvant chemotherapy
    Zhang, Y. Y.
    Gu, K. S.
    Wu, H. Y.
    Yang, F.
    Bu, L. J.
    Zhao, C. C.
    Zhang, Y. R.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 15921 - 15929
  • [24] ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
    Sara De Dosso
    Elena Zanellato
    Martina Nucifora
    Renzo Boldorini
    Angelica Sonzogni
    Roberto Biffi
    Nicola Fazio
    Eraldo Bucci
    Ottavio Beretta
    Stefano Crippa
    Piercarlo Saletti
    Milo Frattini
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 159 - 165
  • [25] ERCC1 mRNA expression and XRCC1 polymorphism as predictive factors for overall survival in gastric cancer patients receiving platinum based chemotherapy
    Wei, J.
    Liu, B.
    Zou, Z.
    Qian, X.
    Zhang, W.
    Yu, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer
    Zhao-Hui Huang
    World Journal of Gastroenterology, 2008, (41) : 6401 - 6407
  • [27] ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer
    Huang, Zhao-Hui
    Hua, Dong
    Du, Xiang
    Li, Li-Hua
    Mao, Yong
    Liu, Zhi-Hui
    Song, Ming-Xu
    Zhou, Xi-Ke
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (41) : 6401 - 6407
  • [28] ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
    De Dosso, Sara
    Zanellato, Elena
    Nucifora, Martina
    Boldorini, Renzo
    Sonzogni, Angelica
    Biffi, Roberto
    Fazio, Nicola
    Bucci, Eraldo
    Beretta, Ottavio
    Crippa, Stefano
    Saletti, Piercarlo
    Frattini, Milo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 159 - 165
  • [29] ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy
    Qin, Xiuguang
    Yao, Wenjian
    Li, Weiwei
    Feng, Xianjun
    Huo, Xiaoqing
    Yang, Shujuan
    Zhao, Hui
    Gu, Xiaomeng
    TUMOR BIOLOGY, 2014, 35 (05) : 4697 - 4704
  • [30] The correlation between ERCC1 expression and outcome of chemotherapy in patients with advanced colorectal cancer (ACC): A Dutch Colorectal Cancer Group study (DCCG)
    Koopman, M.
    Venderbosch, S.
    Antonini, N. F.
    van Krieken, J. H.
    Punt, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345